Spectranetics Corporation
19 clinical trials · Sponsor
◉ Watch Spectranetics Corporation
| Record | Firm | Date |
|---|---|---|
| Tack Optimized Balloon Angioplasty Post-Market Study (NCT05361967) | Spectranetics Corporation | 2023-03-30 |
| ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (NCT03395236) | Spectranetics Corporation | 2018-04-20 |
| TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions (NCT03306199) | Spectranetics Corporation | 2017-10-03 |
| Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (NCT03284229) | Spectranetics Corporation | 2017-09-20 |
Track Spectranetics Corporation automatically
Every clearance here is in the API, with alerts when new ones post.